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Whey protein hydrolysisThe bioavailability of amino acids frommilkwhey protein hydrolysates was evaluated using diffusion of the sub-
stances through semi-permeable membranes (dialyzability) and transport by Caco-2 cell cultures. The hydroly-
sates with low degree of hydrolysis (LDH) and high degree of hydrolysis (HDH) were obtained after 120 min of
reaction time at 50 °C after the initial addition of pepsin, followed by the addition of trypsin, chymotrypsin and
carboxypeptidase-A. The proteins and hydrolysates were further subjected to in vitro digestion with pepsin
plus pancreatin. HPLC was used to determine the concentrations of dialyzable amino acids (48.4% of the non-
hydrolyzed proteins, 63.2% of the LDH sample and 58.3% of the HDH sample), demonstrating the greater
dialyzability of the hydrolysates. The LDH and HDH whey protein hydrolysates prepared with pepsin, trypsin,
chymotrypsin and carboxypeptidase-A showed only 14.7% and 20.8% of dialyzable small peptides and amino
acids, respectively. The efﬁciency of absorption was demonstrated by the preferential transport of Ile, Leu and
Arg through a layer of cells. In the LDH hydrolysate, Tyr was also transported. Prior high- and low-degree hydro-
lysis of the whey provided transport by 5.7% and 6.6%, respectively, in comparison with 2.3% for non-hydrolyzed
proteins, considering the total amount of these amino acids that was applied to the cells.
© 2014 Elsevier Ltd. All rights reserved.1. Introduction
Bovine cheese whey, a greenish-yellow aqueous phase that appears
after the separation of casein coagulated by the action of the enzyme
rennin, is a dairy byproduct of cheese and casein manufacturing
(Smithers, 2008). Theworld production ofwhey increases in proportion
to the growth of the dairy industry, approximately 42% per year on av-
erage (Thivend, 1978). The whey contains approximately 50% of total
milk solids, and 20% of the total milk solids consist of protein
(Smithers, 2008). β-Lactoglobulin and α-lactalbumin are among the
most abundant proteins; they have outstanding nutritional value
(high content of essential amino acids) and are important providers of
bioactive peptides (Clare & Swaisgood, 2000; Pihlanto-Leppälä, Rokka,
& Korhonen, 1998; Shah, 2000). Of all protein sources, bovine cheese
whey protein contains the highest concentration of the branched-
chain amino acids L-leucine, L-valine and L-isoleucine (Walzem, 2004).
Whey protein hydrolysis has been proposed as a process to recover
the highly nutritive content of this waste material (Custódio et al.,
2005; Galvão, Silva, Custódio, Monti, & Giordano, 2001; Guadix,+55 16 3301 6920.
rt), montiru@fcfar.unesp.br
ghts reserved.Guadix, Páez-Dueñas, González-Tello, & Camacho, 2000; Monti & Jost,
1978). There are historical references to the use of whey for medicinal
purposes, such as the treatment of sepsis, wound healing and stomach
diseases and to the existence of prosperous “whey houses” in Europe
in the 17th and 18th centuries. Many nutritional and therapeutic prop-
erties of whey have been reported (Smithers, 2008).
Themainmethods for the analysis of protein hydrolysates have been
described by Silvestre (1997), and the biological properties of whey
proteins and peptides have been described by Madureira, Pereira,
Gomes, Pintado, and Malcata (2007), and Madureira, Tavares, Gomes,
Pintado, and Malcata (2010). Sinha, Radha, Prakash, and Purnima
(2007) described the functional properties and nutritional quality of
whey hydrolysates, which exhibit greater in vitro digestibility than un-
hydrolyzed whey. The in vitro assessment of bioavailability involves
mimicking gastrointestinal digestion with commercially available en-
zymes, followed by the diffusion of the substances through a semi-
permeable membrane to represent their dialyzability (after a period of
equilibrium) (Chiplonkar, Agte, Tarwadi, & Kavadia, 1999; Luten et al.,
1996; Miller, Schricker, Rasmussen, & Van Campen, 1981). In recent
years, the absorption and bioavailability of dietary supplements and
drugs have also been evaluated with Caco-2 cell cultures (Pinto,
Robine-Leon, Appay, & Kedinger, 1983; Herold, Besemer, & Rogler,
1994; Au & Reddy, 2000; Rubio & Seiquer, 2002; Chang-Shu, Glahn, &
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2009; Kotake-Nara, Yonekura, & Nagao, 2010). Caco-2 cells, derived
from a human colorectal adenocarcinoma, have been extensively used
for over 30 years as a model for the study of absorption, metabolism
and toxicity; they can differentiate into monolayers with a phenotype
with many functions of the small intestinal villus epithelium, with
many of the brush border enzymes and transport proteins mediating
the active transport or efﬂux of molecules (Artursson, Palm, &
Luthman, 2012; Ferruzza, Rossi, Scarino, & Sambuy, 2012; Hubatsch,
Ragnarsson, & Artursson, 2007).
The present study differs from previous investigations because the
whey proteins used were obtained from fresh whey. This involves
avoiding protein denaturation or the variability due to different
methods of concentration, heating or procedures for isolation and frac-
tionation (Schmidt, Packard, &Morris, 1984), seeking thereby to use the
protein in itsmore native formas possible and give a destination ecolog-
ically correct to the whey, producing high value-added materials.
The aims of the present studywere to determine the best treatments
for the low-degree and high-degree hydrolysis of whey proteins with
commercially available proteolytic enzymes and the bioavailability of
the released amino acids inwhey hydrolysates by two in vitromethods,
dialyzability and transport by Caco-2 cells.
2. Materials and methods
2.1. Bovine cheesewhey production and analysis of pH, reducing sugars and
protein content
Cheese whey was prepared by adding 0.6% (v/v) animal rennin and
0.3% CaCl2 solution (0.5mol L−1) to bovinemilk and incubating at 37 °C
for one hour. The insoluble portion (caseins) wasﬁltered offwith gauze,
and the whey ﬁltrate was dialyzed for 12 h against distilled water, and
then ﬁltered through kaolin (20 g L−1). The pH was read on a Mettler
Toledo FiveEasy pH meter. Protein concentration (Hartree, 1972) and
reducing sugars (Miller, 1959) were analyzed with an Ultrospec 3100
Pro spectrophotometer (GE Healthcare, Pittsburgh, USA).
2.2. Hydrolytic enzymes
Stock solutions of 0.5 mg.mL−1 of pepsin (1290 units mg−1 pro-
tein), chymotrypsin (55 units mg−1 protein) and trypsin (1300 BAEE
units mg−1 solid) were prepared. Carboxypeptidase-A (50 units mg−1
protein) was prepared at a concentration of 0.025 μL mL−1. All enzymes
were purchased from Sigma Aldrich (St. Louis, MO, USA) and dissolved
in deionized water.
2.3. Cheese whey hydrolysis
The whey was subjected to ﬁve hydrolysis treatments. For treat-
ments 1 and 2, the whey was adjusted with 1% (w/v) ascorbic acid to
a ﬁnal pH of 3.0. The temperature was 37 °C in treatment 1 and 50 °C
in treatment 2. At the start of hydrolysis, 0.666mL stock pepsin solution
was added to 10 mL of whey. After 20 min, the pH was adjusted to 9.5
with 0.1 mol L−1 sodium hydroxide and the enzymes trypsin, chymo-
trypsin and carboxypeptidase A were then added in sequence in the
same volumetric ratio as the pepsin (0.666mL). The hydrolysis reaction
continued for an additional 120 min.
In treatment 3, the whey was adjusted to pH 3.0, as above, and the
hydrolysis temperature was set to 50 °C. When this temperature was
reached, the pepsin was added, starting the reaction. After 20 min, the
suspension (whey + pepsin) was heated for 2 min at 100 °C to inacti-
vate the pepsin, then cooled to 37 °C and buffered to pH 9.5. The
enzymes trypsin, chymotrypsin and carboxypeptidase (0.666 mL
each)were then added in sequence as described for treatments 1 and 2.
Treatments 4 and 5 followed the same temperature pattern as
treatments 1 and 2, respectively, and hydrolysis with pepsin occurredduring the ﬁrst 20 min of the reaction. After buffering to pH 9.5, the
other enzymes were added as follows: trypsin at 20 min of reaction,
chymotrypsin at 30 min of reaction and carboxypeptidase at 40 min of
reaction. Hydrolysis was stopped after the reaction had proceeded for
a total of 120 min.
2.4. Characterization of hydrolysates
The McDonald and Chen (1965) method was used to estimate the
total amount of the reaction product released by the enzymes. This
method permits the determination of peptide bonds and tyrosine and
tryptophan in the reaction medium. Aliquots were taken at 10, 20, 40,
60, 90 and 120 min and analyzed. The absorbance was read at
700 nm. The calibration curve was generated using tyrosine (Sigma)
as the standard. The absorptivity was taken as 0.511 (μmol mL−1) cm−1.
2.5. HPLC analysis of whey hydrolysis products
For all treatments, samples were taken after 120 min of reaction,
boiled for 3 min to inactivate the enzymes and frozen for subsequent
analysis by high-performance liquid chromatography (HPLC). Aliquots
of 20 μL were injected into a Varian ProStar or Shimadzu LC 10A
employing a Nucleosil C18 reversed-phase column (25 × 0.46 in.;
5 μm particle size; 300 Å pore size) with a 5 to 95% linear gradient of
solvent B (A: water, 0.045% triﬂuoracetic acid (TFA); B: acetonitrile
(ACN), 0.036% TFA) as the mobile phase, ﬂowing 1.0 mL min−1 for
30 min. UV detection was performed at 220 nm.
Amino acid analyses were performed by post-column
functionalization with o-phthalaldehyde (OPA) in automatic ana-
lyzer Shimadzu model LC-10A/C-47A with ﬂuorescence detector,
equipped with ion-exchange column Shimadzu model Shim-pack
for amino acid analysis. The ﬂow rate used was 0.6 mL min−1 and
the mobile phase consisted of:
- Mobile phase A: sodium citrate 19.6 g, 99.5% ethanol 140 mL, 60%
perchloric acid 16.7 mL, ﬁnal volume 1 L, pH 3.1;
- Mobile phase B: sodium citrate 58.8 g, boric acid 12.4 g, 4.0 M sodi-
um hydroxide solution 30 mL; ﬁnal volume 1 L, pH 10.0;
- Mobile phase C: 0.2 M sodium hydroxide solution, pH 13.5.
The system was calibrated with a standard mixture of amino acids,
yielding a value for the elution time of each amino acid and the conver-
sion factor between the area of each peak and the sample concentration.
2.6. Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
At various time intervals (10, 20, 40, 60, 90 and 120 min),
aliquots of 200 μL were removed from the enzymatic assay, and an
equal volume of sample preparation buffer (Tris-glycine, glycerol,
SDS, β-mercaptoethanol and bromophenol blue)was added and samples
heated for 3 min at 100 °C, then stored at 4 °C until electrophoresis. SDS-
PAGE (12%) was performed by Laemlli (1970) method. Aliquots of 25 μL
were loaded on the gel in sample wells, one of which carried 10 μL of a
standard molecular weight ladder (GE Healthcare) consisting of phos-
phorylase b (97 kDa), bovine serum albumin (66 kDa), ovalbumin
(45 kDa), carbonic anhydrase (30 kDa), trypsin inhibitor (20.1 kDa)
and α-lactalbumin (14.4 kDa). The gel plate was run for 2 h at 40 mA,
and then stained with silver (Blum, Beier, & Gross, 1987) and colloidal
Brilliant Blue G (Neuhoff, Stamm, & Eibl, 1988).
2.7. In vitro gastrointestinal digestion of whey proteins and hydrolysates
The in vitro digestion method was previously described by Miller
et al. (1981) and modiﬁed by Luten et al. (1996). Prior to digestion,
0.48 g of commercial pepsin (Sigma) of speciﬁc activity 1290 U mg
prot−1 was dissolved in 3 mL of 0.1 mol.L−1 HCl. The pH of 95 mL
samples of whole whey proteins and their various hydrolysates was
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Fig. 1. Total units of amino acids released after bovinewhey protein hydrolysis by ﬁve dif-
ferent enzymatic hydrolysis treatments. Treatments conditions are described in Materials
and methods. Values are the mean ± standard deviation of three experiments.
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the pepsin solution was added, and the volumewas adjusted to 100mL
with Milli-Q water. The suspension was incubated in a shaking water
bath at 37 °C for 2 h. Following enzymatic digestion, 20 mL aliquots of
the digestswere adjusted to pH7.5with 0.5mol L−1 NaHCO3. Segments
of pretreatedmembrane tubes containing 25mL of 0.5mol L−1 NaHCO3
solution were carefully immersed in beakers containing the enzymatic
digest, followed by the addition of 5.0 g of a pancreatin-bile extract
containing 20 mg of pancreatin and 125 mg of bile extract (Sigma) in
5mL of 0.5mol L−1 NaHCO3 solution. The suspensionwas then incubat-
ed in a shakingwater bath at 37 °C for 2 h to complete the digestion and
facilitate the diffusion of small peptides and amino acids. The solution
outside, the external digest (Dext), and the solution inside the mem-
brane, the internal digest (Dint) were stored separately at−18 °C for
subsequent experiments.
2.8. Caco-2 cell culture
Caco-2 cells were kindly provided by Dr. Rosário Dominguez Crespo
Hirata of the Department of Clinical Analyses and Toxicology at the
School of Pharmaceutical Science, University of São Paulo, Brazil. The
cells were maintained in DMEM minimal essential medium (Sigma)
with 10% (v/v) fetal bovine serum (South American cod. 12657029),
1% (v/v) non-essential amino acids (MEN non-essential amino acids,
Sigma, lot RNBB 3743), 1% (v/v) glutamine (L-glutamine solution
Bioxtra, 200 mmol L−1, SO, lot RNBB 2939, Sigma) and 1% (v/v)
antibiotic-antimycotic solution 100× (lot BCBB 8363, Sigma), at
pH 7.2 to 7.4, and incubated at 37 °C at 5% CO2 and constant humidity.
The culturemediumwas replaced every two days. Cells at approximately
80% conﬂuence were recovered with a trypsin-EDTA solution (2.5 g L−1
of trypsin and 0.2 g L−1 of EDTA, Sigma) and used for new transfers or
seeded in cell culture ﬂasks with a growth area of 25 cm2 or 75 cm2
(Corning Incorporation), at a density of approximately 6000 cells/cm2
for continuous growth or 20,000 cells/insert in the absorption
experiments.
2.9. Cytotoxicity assay
Cell viability was measured by the sulforhodamine B (SRB) assay.
Cells were added to 96-well plates (6 × 103 cells/well), and the culture
wasmaintained at 37 °C under 5% CO2. The cells were allowed to attach
for 24 h, and test compounds [non-hydrolyzed (NH)whey proteins and
hydrolysates with a low degree of hydrolysis (LDH) or high degree of
hydrolysis (HDH)] underwent gastrointestinal digestion in the absence
of a membrane. These samples were added to DMEM supplemented
with 10% fetal bovine serum. In the wells of the ﬁrst row, 10 μL of the
test compounds at an initial concentration 60 μg μL−1 was dispensed
and serial dilutions from 600 to 18.8 μg/well, as described by Oliver,
Harrison, Bishop, Cole, and Laurent (1989). The assay was terminated
after 24 h by removing the medium from the well.
For the SRB assay, cells were then washed twice with ice-cold phos-
phate buffered saline (PBS), prior to ﬁxation with 10% TCA (100 μL per
well) at 4 °C for 30 min. Each well was washed with tap water ﬁve to
six times and dried. SRB (0.4%) dissolved in 1% acetic acid was added
and incubated for 30 min. The wells were washed ﬁve to six times
with 1% acetic acid and dried. Tris base (10 mmol L−1, pH 10.5) was
added to each dried well. The optical density was measured at 530 nm
with a microplate reader (Molecular Device, Versa Max, USA).
2.10. Bioavailability studies in Caco-2 cells
For each experiment, Caco-2 cells were seeded and grown for 21
days in culture platewell inserts to obtain conﬂuent, highly differentiat-
ed cell monolayers. At the beginning of each experiment, the cell mono-
layers were washed with 0.5 mL PBS and treated with 10 μL of the test
compounds at an initial concentration of 6 μg μL−1 in transport buffer(Perales et al., 2005) containing 130 mmol L−1 NaCl, 10 mmol L−1 KCl,
1 mmol L−1 MgSO4, 5 mmol L−1 glucose and 50 mmol L−1 HEPES,
pH 7.0, at 37 °C. After 2 h of incubation at 37 °C in 5% CO2, media from
the upper and lower chambers were harvested and separately analyzed
by HPLC.
3. Results
3.1. Production of whey protein hydrolysates under various conditions of
hydrolysis
Five different treatments were investigated for the production of
hydrolysates from whey proteins. As shown in Fig. 1, treatment 5
(50 °C; initial hydrolysis with pepsin for 20 min, followed by the
sequential addition of trypsin, chymotrypsin and carboxypeptidase-A
at ten-minute intervals) resulted in the greatest hydrolysis of the
proteins after 120 min, as evidenced by a greater quantity of peptides
and/or tyrosine and tryptophan units than that in other treatments
(temperature, sequence of enzyme addition, boiling to inactivate
pepsin). The improved efﬁciency of treatment 5 may have been due to
the separate addition of the enzymes, which could lead to enhanced
hydrolytic activity, because the enzymes employed show speciﬁcity to
particular amino acids sequences in the polypeptide chain. Treatment
3 produced the second largest amount of peptides. Therefore, for subse-
quent experiments, these two treatments were employed to produce
hydrolysates that were termed LDH [sample with a lower degree of
hydrolysis (treatment 3)] and HDH [sample with a higher degree of
hydrolysis (treatment 5)].
3.2. HPLC and SDS-PAGE analysis of LDH and HDH
The SDS-PAGE and HPLC analysis of the samples obtained under
hydrolysis treatments 3 and 5 conﬁrmed the greater catalytic efﬁciency
of the latter treatment. Fig. 2 (lanes 2 to 7) shows the SDS-PAGE analysis
of LDH, which demonstrates that some proteins were not completely
hydrolyzed and a number of small peptides were observed near the
bottom of the gel. Under treatment 5, these small peptides completely
disappeared after 60 min of hydrolysis (Fig. 2, lanes 8 to 13).
The analysis of the HPLC chromatograms conﬁrmed the SDS-PAGE
ﬁndings. Due to their structural characteristics, the hydrophobic
portions of the proteins are exposed in the polar medium, enhancing
its interaction with the reverse phase of the matrix. Under typical
conditions, the proteins are desorbed from the reverse phase of the
gel matrix as the polarity of the solvent in the mobile phase is reduced,
resulting in longer retention times than for small peptides, which are
Fig. 2. SDS-PAGE of whey proteins hydrolyzed under treatment 3 (lanes 2 to 7) and treatment 5 (lanes 8 to 13). Lane 1: molar mass standard (GE Healthcare). Lanes 2 to 7 and 8 to 13:
products after reaction for 10, 20, 40, 60, 90 and 120 min.
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cated that more efﬁcient enzymatic hydrolysis occurred after 120 min
under treatment 5 than under treatment 3. A greater number of peaks
representing adsorbed peptides was observed under treatment 3
(LDH) at retention times greater than 20 min, demonstrating the
presence of hydrophobic peptides and a lower degree of hydrolysis
(Fig. 3A), whereas no peptide links were observed under treatment 5
(HDH) at the retention time, demonstrating greater catalytic efﬁciency
(Fig. 3B).
3.3. Gastrointestinal digestion and dialyzability of proteins and hydrolysates
The dialyzability of proteins and their hydrolysates produced with
the commercial proteinases pepsin, trypsin, chymotrypsin and
carboxypeptidase-A was tested after digestion with pepsin, pancreatin
and bile salts. Table 1 displays the analysis of proteins, peptides and ty-
rosine and tryptophan after gastrointestinal digestion of the integral
whey proteins and their hydrolysates. A total of 4.41 ± 0.16 g L−1 of
protein was determined in the external digest of the non-hydrolyzed
whey, whereas this amount was reduced by 52.4% in the LDH and
60.5% in the HDH digests, demonstrating that the latter hydrolysis facil-
itated the action of gastrointestinal enzymes on the whey proteins. The
results also revealed a small amount of peptides and/or tyrosine and
tryptophan (0.038 total U) in the non-hydrolyzed whey. After gastroin-
testinal digestion, however, the amount of peptides and/or tyrosine and
tryptophan increased by 894.7% to 0.34 total U, of which 38.2% (0.13
total U) was dialyzable, indicating satisfactory diffusion of these reac-
tion products, in agreement with ﬁndings reported in the literature
(Argyri et al., 2009; Bermejo et al., 2002; Romarís-Hortas et al., 2011).
The LDHhydrolysate contained 0.384 total U of peptides and/or tyrosine
and tryptophan (1010.5% greater), ofwhich 29.7%wasdialyzable (0.114Fig. 3. HPLC proﬁle of cheese whey hydrolysis products after a 120 min rtotal U). The HDH hydrolysate contained 0.542 total U of peptides and/
or tyrosine and tryptophan (1426.3% greater), of which 31.7% (0.172 U)
was dialyzable.
Fractions of the external and internal predicted gastrointestinal
digests of the non-hydrolyzed whey proteins (DextNH and DintNH,
respectively) were analyzed by SDS-PAGE (results not shown) and
HPLC, which revealed a high degree of hydrolysis based on the presence
of dialyzable peptides and amino acids, demonstrating satisfactory
agreement with the levels determined by the method described by
McDonald and Chen (1965), (Table 1). The results are displayed in the
aminograms (Fig. 4), which indicate 16 amino acids in the DextNH and
17 in the DintNH. High concentrations of leucine and lysinewere detected
in the DintNH (339.67 and 314.15 nmol L−1, respectively).
The SDS-PAGE analysis of the fractions of the gastrointestinal digests
of the LDH and HDH hydrolysates is shown in Fig. 5. The disappearance
of protein bands in the DintLDH lane indicates protein hydrolysis,
whereas the proteins were not completely hydrolyzed in the DextLDH
(lane 3). Moreover, a greater reduction in polypeptides was observed
in DextHDH (lane 5) than that in DextLDH, and no protein bands were
observed in the DintHDH (lane 6). Thus, even after prior hydrolysis of
proteins and gastrointestinal digestion, resistant polypeptides (larger
than 12 kDa) remained on the external side of the membrane.
Aliquots were analyzed by reverse phase HPLC to investigate the
composition and concentration of amino acids in the fractions of the
LDH and HDH gastrointestinal digests. Fig. 6 displays the aminograms
resulting from the LDH and HDH fractions recovered inside the mem-
brane, demonstrating the presence of 14 amino acids. The comparison
of relative concentration of the dialyzable amino acids after enzymatic
digestion of cheese whey proteins (internal NH digest) and LDH
hydrolysates (internal LDH digest) indicated greater dialyzability for
Asp, Thr, Glu, Pro, Gly and Arg from internal LDH digest and reducedeaction. A: condition 3 (sample LDH); B: condition 5 (sample HDH).
Table 1
Total analysis of the whey proteins, peptides and amino acids before and after in vitro gastrointestinal digestion.
Steps Proteins (g L−1)a Peptides and/or tyrosine and tryptophanb
External gastrointestinal digest (DextNH) 4.41 ± 0.16 0.210 ± 0.012
Internal gastrointestinal digest (DintNH) 2.14 ± 0.06 0.130 ± 0.005
External gastrointestinal digest (DextLDH) 2.10 ± 0.04 0.270 ± 0.011
Internal gastrointestinal digest (DintLDH) 0.68 ± 0.02 0.114 ± 0.055
External gastrointestinal digest (DextHDH) 1.74 ± 0.03 0.370 ± 0.004
Internal gastrointestinal digest (DintHDH) 0.55 ± 0.01 0.172 ± 0.006
a Protein determined by method of Hartree 26.
b Peptides and/or tyrosine and tryptophan determined bymethod of McDonald & Chen 28. DextNH: non-hydrolyzed proteins external digest; DintNH: non-hydrolyzed proteins internal
digest; DextLDH: low degree of hydrolysis external digest; DintLDH: low degree of hydrolysis internal digest; DextHDH: high degree of hydrolysis external digest; DintHDH: high degree of
hydrolysis internal digest.
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Cys and Ile were not detected in the LDH digest. Comparing the results
of the internal NH digest and internal HDH digest, greater dialyzability
was found for Asp, Thr, Glu, Pro, Gly, Ala, Leu, Tyr, Phe, Lys and Arg
from the HDH digest, and reduced dialyzability for Val, Met and His.
As for LDH, Ser, Cys and Ile were not detected in the HDH digest. Thus,
for the internal LDH and HDH samples, the dialyzability of the majority
of amino acids (Asp, Thr, Glu, Pro, Gly, Ala, Val, Met, Leu, Phe, His, Lys
and Arg) was greater than that with the internal NH sample (Table 2,
lane % Internal of each sample), suggesting that gastrointestinal diges-
tion enhanced the dialyzability of the amino acids in the hydrolysates:
63.2% of the internal LDH and 58.3% of the internal HDH sample were
dialyzed, compared to only 48.4% of the internal NH sample. These
ﬁndings demonstrate the importance and efﬁciency of the priorFig. 4. Cheese whey protein aminograms after gastrointestinal digestion. A:hydrolysis of whey proteins for the enhanced permeation of small
peptides and amino acids. The LDH andHDHwhey protein hydrolysates
prepared with pepsin, trypsin, chymotrypsin and carboxipetidade-A
and without subsequent gastrointestinal digestion treatment, showed
only 14.7% and 20.8% of dialyzable small peptides and amino acids,
respectively.
3.4. Transport of amino acids through a monolayer of Caco-2 cells
For the absorption and transport studies, 100-μL fractions of samples
NH, LDH and HDH (6.0 μg of supplements per 1.0 μL of transport buffer)
were added to the apical side of a monolayer of Caco-2 cells. After
incubation for 2 h, the material remaining on the apical side and that
transported to the basal side were analyzed by HPLC. Fig. 7 displaysDextNH; B: DintNH. Conditions are described in Materials and methods.
Fig. 5. SDS-PAGE of the cheese whey proteins and their hydrolysates before and after
dialyzability. Lanes: 1 —molecular mass standard; 2 — NH (whey proteins); 3 — DextLDH
(external gastrointestinal digest); 4 — DintLDH (internal gastrointestinal digest); 5 —
DextHDH (external intestinal digest); 6 — DintHDH (internal intestinal digest).
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onstrating that the previous treatments of the whey protein samples
affected the types of amino acids produced and transported through
the monolayer of Caco-2 cells. In all three samples tested, the main
amino acids that permeated the monolayer were Ile, Leu and Arg.
Tyrosine was also transported but only in the LDH sample. Considering
the relative concentrations of amino acids Ile, Leu, Tyr and Arg
determined in the samples (490,0 nM, 307,8 nM and 895,7 nM forFig. 6. Aminograms of cheese whey protein hydrolyLDH, HDH e NH, respectively), the cell culture exerted selectivity, and
transported 6.6% of these amino acids from the LDH sample, followed
by the HDH sample (5.7%) and ﬁnally the NH sample (2.3%) (Fig. 7).
Thus, as observed with regard to dialyzability, previous hydrolysis of
whey proteins also enhanced the transport of amino acids. Moreover,
the SRB assays demonstrated that the whey proteins and the
hydrolysates produced were not cytotoxic to Caco-2 cells under the
conditions employed in the present study.
4. Discussion
Numerous investigations have been conducted in recent decades
and how tomake use of whey, a dairy byproduct composed of multiple
proteins (Clare & Swaisgood, 2000; Custódio et al., 2005; Galvão et al.,
2001; Ha & Zemel, 2003; Liu, Zhu, & Zhao, 2008; Madureira et al.,
2010). Most of these studies have been performed on dry whey protein
concentrate or whey protein isolates, which are less soluble compared
to the fresh milk whey used in this work. These proteins have a wide
range of applications due to their considerable biological value. Biological
value is a measure of the percentage of a given nutrient used by the body
and is related to the extent with which the body uses the protein
consumed. The biological value of whey proteins is exceptional and
exceeds that of egg proteins by approximately 15%. The present study
differs from previous investigations because the whey proteins used
were in a more native state because they were obtained from fresh
whey, thereby avoiding extra new processes such as separation or con-
centration. After two hydrolysates were produced, with the enzymes
pepsin, trypsin, chymotrypsin and carboxypeptidase-A, gastrointestinalsates after dialyzability. A: DintLDH; B: DintHDH.
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68 A.J. Goulart et al. / Food Research International 63 (2014) 62–70digestion was simulated in vitro, and two methods (dialyzability and
transport across a Caco-2 cell culture) were used to determine the diffu-
sion and transport potential of the amino acids released.
In the present study, several sets of conditions for the production of
the hydrolysates were investigated; a reaction time of 120 min at 50 °C
yielded the best catalytic efﬁciency. Another important condition was
initial hydrolysis with pepsin for 20 min, at 50 °C, followed by the
sequential addition of the other enzymes at 10-min intervals, which
enhanced hydrolysis and amino acid release.
The proteins found in whey have high contents of essential amino
acids, sulfated amino acids and branched-chain amino acids in their
polypeptide chains; these amino acids are involved in the synthesis of
proteins, the homeostasis of glucose and lipid metabolism (Ha &
Zemel, 2003; Smithers, 2008). For this reason, whey proteins are
typically used to supplement diets that are low in protein (Volpi,
Kobayashi, Shefﬁeld-Moore, Mittendorfer, & Wolfe, 2003). Since the
quality of whey proteins and their ability to be rapidly metabolized
and absorbed are widely recognized (Jakubowicz & Froy, 2013), a
large number of studies have been performed to optimize the use of
these products for nutritional and functional purposes, as well as to
investigate their interactions with other compounds (Smithers, 2008).
Among these studies, enzymatic hydrolysis is widely employed for
the release of biologically active substances and free amino acids
(Sinha et al., 2007) and, given their nutritional quality and functional ca-
pacity, hydrolysates of whey proteins have attracted considerable inter-
est from the food, pharmaceutical and cosmetic industries. However,
despite progress in the production of whey protein hydrolysates with
various enzymes, the antigenicity of these products needs to be studied
further (Liu et al., 2008). Methods simulating gastrointestinal digestion
have been widely used to generate diverse hydrolytic products by the
action of digestive enzymes and to determine the behavior of these
products in vitro. Among such methods, cell culture (particularly of
Caco-2 cells) and dialyzability assays are frequently employed because
thesemethods are carried out in conditions similar to physiological gas-
trointestinal digestion,with regard to temperature, pHand the digestive
enzyme complex, and allow prediction of the diffusion and absorption
rates of bioactive components of foods and pharmaceutical drugs
(Hur, Lim, Decker, & McClements, 2011). A dialyzability assay is an
in vitro method that involves a two-phase digestive process. This tech-
nique simulates gastric and intestinal digestion by dialysis through a
semi-permeable membrane with controlled pores. Dialyzability assays
offer the advantages of fast results, low cost and signiﬁcant correlation
with in vivo studies, with respect to the total fraction of test substance
that is available for absorption (Sandberg, 2005).
It's necessary to remember that these models are just predictive
models andwhat happens in the gastrointestinal tract may be different.
In the present study, the dialyzability assay was used to determine the
behavior of whey proteins and LDH and HDH hydrolysates under simu-
lated gastrointestinal conditions, with respect to the release of amino
acids and their diffusion through a semi-permeable membrane. When
the NH (non-hydrolyzed) sample was subjected to gastrointestinal di-
gestion, the subsequent dialyzability assay revealed that all essential
amino acids were released. The same result was obtained with the
LDH and HDH hydrolysates, with the exception of isoleucine. Analysis
of the percentage of dialysis of the detected essential amino acids
(Table 2) demonstrated that Leu, Lys and Thr in the LDH hydrolysate
was released in slight greater concentration than that from HDH,
whereas Phe concentration was virtually the same in the LDH and
HDH samples. Essential branched-chain amino acids, such as Leu, Ile
and Val, which are involved in protein synthesis, glucose homeostasis
and lipid metabolism, were detected in at least one sample. The same
was true for the S-containing amino acids Cys and Met, which play cru-
cial roles as antioxidants and precursors of glutathione and are also in-
volved in themetabolism of carbon (Ha& Zemel, 2003; Smithers, 2008).
LHD sample showed higher amount of dialyzable peptides and
amino acid than that of HDH sample. One hypothesis for the greater
57.1
30.9
13.9 16.1
3.6 2.2 0 5.110
20
30
40
50
60
70
80
90
100
Ile Leu Tyr Arg
R
el
at
iv
e 
pe
rc
en
ta
ge
 *
NH
Apical (upper) Basal (lower)
76.6
41.1
20.3
26.9
8.1 4.1 0
21.8
10
20
30
40
50
60
70
80
90
100
Ile Leu Tyr Arg
R
el
at
iv
e 
pe
rc
en
ta
ge
 *
HDH
Apical (upper) Basal (lower)
22.7
14.1 15.8
26.7
6.7 4.4 6.1
16.8
10
20
30
40
50
60
70
80
90
100
Ile Leu Tyr Arg
R
el
at
iv
e 
pe
rc
en
ta
ge
 *
LDH
Apical (upper) Basal (lower)
100.0 100.0 100.0
25.0
16.9
35.3
2.3 6.6 5.7
0
20
40
60
80
100
120
NH LDH HDH
R
el
at
iv
e 
pe
rc
en
ta
ge
**
Total of Ile, Leu, Tyr and Arg applied and 
transported by Caco-2 cells
Applied Apical side Basal side
Fig. 7.Amino acids transported through a Caco-2 cellmonolayer. *In relation to the total of each applied amino acids. **In relation to the total applied amino acids (Ile+ Leu+Tyr+ Arg).
Values are the mean of three experiments and standard deviation b5%.
69A.J. Goulart et al. / Food Research International 63 (2014) 62–70diffusion of the LDH sample amino acids is the presence of peptides larg-
er than 12 kDa, which can't cross the membrane, however exercising a
high osmotic pressure, offset by the greater diffusion of these amino
acids until equilibrium. Amino acids in hydrolysate HDH are in greater
concentration than those in the hydrolysate LDH, but the peptides are
smaller, exerting lower osmotic pressure. This effect occurs because
in vitro systems are closed, with ﬁxed time of two hours (in our
experiments), without continuous removal of the amino acids diffused,
as in a living system.
On the basis of the present experiments, whey proteins (whether
hydrolyzed or not) constitute a considerable source of amino acids
when subjected to gastrointestinal digestion and possess signiﬁcant
dialyzability. However, diffusion through themembrane was not corre-
lated with the relative concentrations of the amino acids detected; de-
spite the relatively lower concentrations of methionine, histidine and
asparagine, these amino acids diffused to the interior of the membrane
at rates exceeding 40%.
The literature includes an increasing number of reports on assessing
the bioavailability of nutrients with cell cultures. Monolayers of cells
fromhuman colon carcinoma line (Caco-2 cells) are themostwidely ac-
cepted predictive model of human intestinal absorption in many indus-
trial labs and are even cited by the US Food and Drug Administration
(Argyri et al., 2009; Fraga, Serrão, & Soares-da-Silva, 2002; Hur et al.,
2011; Natoli et al., 2011). The present study is in line with these
investigations and, moreover, the whey proteins used were in the
most natural form possible for the production of hydrolysates, rather
than using protein concentrates or isolates.
Leu, Ile and Arg were transported by the monolayer from all three
samples, whereas Tyr was only transported from the LDH sample
under the conditions of the experiment (Fig. 7). In contrast to the results
of the dialyzability experiment, in which all amino acids applied were
found inside of the membrane, the cells demonstrated selectivity or
preference in the transport of amino acids. Among the amino acidsevaluated, Leu was one of the most easily dialyzed and also transported
through the monolayer of Caco-2 cells in the present study.
The amino acid Leu is of particular interest because it has been
reported to play a crucial role inmetabolism and the regulation of protein
synthesis, has been identiﬁed as a key activator of the mTOR signaling
pathway and is involved in the reversible phosphorylation of proteins
that control the bonding of mRNA to the 40S subunit of ribosomes (Ha
& Zemel, 2003). Leu has also been identiﬁed as a pharmaconutrient
with the potential to promote muscle hypertrophy, thereby preventing
or minimizing sarcopenia (progressive loss of muscle mass and strength
stemming from the aging process) (Katsanos, Kobayashi, Shefﬁeld-
Moore, Aarsland, & Wolfe, 2006; Leenders & van Loon, 2011; Volpi
et al., 2003). It is estimated that muscle mass is reduced by 3 to 8% per
decade after reaching the age of 30 years, sarcopenia resulting in a greater
than 30% loss of muscle mass in individuals aged 60 years or older and
50% loss of muscle mass in those aged 80 years or older (Paddon-Janes
& Rasmussen, 2009). Moreover, sarcopenia leads to the functional capac-
ity loss predisposing to the development of chronic metabolic disease,
such as obesity or type 2 diabetes (Leenders & van Loon, 2011). Whey
has a 50 to 75% greater Leu content than that of other protein sources;
this high Leu content would likely promote the synthesis of muscle pro-
tein and a possible thermogenic effect (Jakubowicz & Froy, 2013). In
patients with type 2 diabetes, the addition of whey to a meal containing
fast-absorbing carbohydrates led to the stimulation of a greater
concentration of insulin (57% greater after lunch) and the reduction of
postprandial blood sugar by 21% after 120 min (Jakubowicz & Froy,
2013).
5. Conclusions
The milk whey protein hydrolysates obtained after treatment with
pepsin, trypsin, chymotrypsin and carboxypeptidase-A showed high
bioavailability of essential and non-essential amino acids compared to
70 A.J. Goulart et al. / Food Research International 63 (2014) 62–70non-hydrolysed whey proteins. The high percentage of amino acids
dialyzed from LDH and HDH samples suggests that the digestion of
the cheese whey proteins is better after a prior hydrolysis. The in vitro
experiment with Caco-2 cells indicated the preferential transport of
amino acids Ile, Leu and Arg from whey proteins (NH), LHD and HDH
digest samples through a layer of cells, and possible effects of these
hydrolysates in the reduction of the sarcopenia in aged rats are being
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